GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group AS (OCSE:PEG) » Definitions » Accounts Payable & Accrued Expense

Pharma Equity Group AS (OCSE:PEG) Accounts Payable & Accrued Expense : kr5.88 Mil (As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group AS Accounts Payable & Accrued Expense?

Pharma Equity Group AS's quarterly accounts payable & accrued expense declined from Mar. 2024 (kr5.38 Mil) to Jun. 2024 (kr4.60 Mil) but then increased from Jun. 2024 (kr4.60 Mil) to Sep. 2024 (kr5.88 Mil).

Pharma Equity Group AS's annual accounts payable & accrued expense increased from Dec. 2021 (kr0.65 Mil) to Dec. 2022 (kr2.19 Mil) and increased from Dec. 2022 (kr2.19 Mil) to Dec. 2023 (kr10.66 Mil).

Pharma Equity Group AS Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pharma Equity Group AS's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group AS Accounts Payable & Accrued Expense Chart

Pharma Equity Group AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.58 3.26 0.65 2.19 10.66

Pharma Equity Group AS Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.74 10.66 5.38 4.60 5.88

Pharma Equity Group AS Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Pharma Equity Group AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group AS (OCSE:PEG) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
OCSE:LOLB OCSE:NRDF OCSE:DJUR OCSE:KRE OCSE:HVID OCSE:VJBA OCSE:MNBA OCSE:LASP OCSE:SPKSJF OCSE:SKJE OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 ALNY XBRU:UCB XBRU:ARGX XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Website
https://www.pharmaequitygroup.com
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .